Spex Capital

Knokcare is a healthcare platform that utilizes an app-based system to provide patients with a comprehensive approach to managing their health. The platform combines AI chatbots, video consultations, and in-home appointments to streamline the healthcare experience. Patients can engage with the AI chatbot for self-assessment, which helps determine the appropriate course of action, whether that be a video appointment or a face-to-face visit. If necessary, the platform can facilitate referrals to hospitals for more serious conditions. Additionally, Knokcare ensures the security of patient records, allowing medical institutions and healthcare providers to deliver effective care while maintaining confidentiality. By integrating various healthcare services into a single application, Knokcare enhances convenience for patients and improves efficiency within the healthcare system.

Skin Analytics, established in 2012 and headquartered in London, specializes in online healthcare services focused on skin health. The company uses smartphone photography and proprietary algorithms to transform images into valuable data, aiding dermatologists in diagnosis and treatment decisions. By building a digital history of the skin, Skin Analytics empowers individuals and healthcare professionals to monitor, track, and understand skin conditions, ultimately improving skin health. The company's patent-pending technology enables early detection of melanoma and other skin cancers, as well as precancerous lesions, with a focus on delivering a range of consumer and clinical skin health products over the next three years.

Log my Care is a provider of electronic care planning and management software aimed at enhancing coordination and communication within care environments. The platform allows care providers to transition from traditional paper-based recording to a streamlined electronic system. It features a shared to-do log that informs care employees of their tasks, while also generating printable reports on activity performance. This functionality enables care managers to maintain oversight of their services efficiently, ultimately facilitating better operational management and improved care delivery.

MediShout Ltd. is a technology company based in London, United Kingdom, that develops a digital platform aimed at enhancing operational efficiency within healthcare environments. Founded in 2013, the company addresses inefficiencies in hospitals, general practices, and care homes by connecting healthcare teams, suppliers, and logistics through its cloud-based solution. MediShout's platform integrates various systems, enabling real-time communication and collaboration among staff and departments. With features such as instant feedback, two-way conversations, and artificial intelligence for predictive analysis, MediShout empowers healthcare providers to improve care delivery, streamline operations, and ultimately focus more on patient care.

Firza Ltd is a healthcare advisory company based in London, UK, specializing in technology-enabled workforce solutions for the healthcare sector. Founded in 2014 and formerly known as Syd Lee Limited, Firza provides a variety of services including medication reviews, prescription reauthorizations, document management, and support for care homes and prisons. The company aims to modernize healthcare operations by leveraging robotic process automation and artificial intelligence, delivering tailored solutions to NHS organizations, general practice teams, and pharmacies. Firza's expertise in primary care allows for quick mobilization and the development of effective strategies that address the unique needs of healthcare providers, ultimately simplifying their daily operations and enhancing service delivery.

LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.

LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.

Skin Analytics, established in 2012 and headquartered in London, specializes in online healthcare services focused on skin health. The company uses smartphone photography and proprietary algorithms to transform images into valuable data, aiding dermatologists in diagnosis and treatment decisions. By building a digital history of the skin, Skin Analytics empowers individuals and healthcare professionals to monitor, track, and understand skin conditions, ultimately improving skin health. The company's patent-pending technology enables early detection of melanoma and other skin cancers, as well as precancerous lesions, with a focus on delivering a range of consumer and clinical skin health products over the next three years.